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ABSTRACT

Gold Nanoparticles have piqued interest for use in a wide range of diagnostic and therapeutic
applications including biosensors, assays, vaccine development, drug delivery, and photothermal
therapy. While extensive research has been conducted, the applications of gold nanoparticles have
yet to see the same level of commercial success as well-established methods such as ELISA and
lateral flow immunoassays. Studies analyzing the efficacy of gold nanoparticle technologies in
vivo and in vitro provide seemingly conflicting results that reflect a further need for investigation
into the biological response of gold nanoparticles. A large factor in the variation is the nature of the
interaction between gold nanoparticles and the immune system. The immune system is among the
first systems involved with the initial interaction with a foreign entity, and is comprised of several
mechanisms for a variety of circumstances. While current studies have begun to provide insight
regarding immunological response to gold nanoparticles, further research is still required. In this
study, the interactions between gold nanoparticles and 13 different immunoglobulin isotypes from
bovine, human, and murine blood were studied using dynamic light scattering, colorimetry, and
UV-Vis spectroscopy. In further testing, gold nanoparticle interaction was monitored in mixed
samples of immunoglobulin isotypes associated with T helper 1 and T helper 2 cell pathways to
potentially observe any change in interaction as the result of a mixed sample. Preliminary results
revealed a potential trend involving a greater increase in absorbance and hydrodynamic radius for
isotypes associated with the T helper 1 cell related immune response. However, certain inconsistent
repeatability of the results was noticed from the mixed immunoglobulin studies, and this
observation seems to indicate the possibility of additional factors contributing to the
immunoglobulin-goldnanoparticle interactions.
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CHAPTER 1: INTRODUCTION

1.1 Gold Nanoparticles

Figure 1.1: TEM images of AuNP synthesized into different shapes, including a) quasi spheres,
b) nanorods, c) nanodumbells, d) triangular nanoprisms, e) Ultrathin nanowires, f) nanostars, g)
nanodendrites (SEM image), h) nanocubes (SEM image)13

Nanoparticles are defined as particles within a size range of 1-100nm24. At this scale, the
properties and characteristics exhibited by matter are typically different from those associated
with the matter at larger scales13, 19-21. Among these, metallic nanoparticles, such gold, silver, and
platinum, have exhibited several characteristic differences that make it ideal for numerous
applications29, 36. Gold nanoparticles (AuNPs), commonly known as colloidal gold in solution,
are metallic nanoparticles that have gained increasing attention for their nanoscale properties.
AuNPs have several inherent properties with prospective use in nanomedical applications, most
notably the enhanced optical properties due to surface plasmon resonance (to be discussed
separately)13, 19. Other characteristics include biocompatibility, low cytotoxicity, the potential
1

for a variety of surface conjugations, and controllable synthesis13, 21. In regard to synthesis, the
citrate reduction method, better known as the Turkevitch method, has been proven to produce
high yield, high quality monodispersed spherical AuNPs. However, due to several advancements
in synthetic development, it is now possible to achieve different shapes (Figure 1.1) such as nanodendrites, stars, rods, and even cubes – all of which have different optical properties and
characteristics that lend itto different applications13, 19, 20, 24.

1.1.1 Gold Nanoparticle Synthesis
The synthesis of AuNPs is the most critical aspect of controlling and fine tuning the optical
properties. Failure in precision can result in variability in size distribution, and therefore
decreasing the advantage of tunable optical properties13,

23, 32, 35

. As previously stated, the

Turkevich method is a common technique for the synthesis of gold nanoparticles. The Turkevich
method is typically used for the synthesis of spherical particles13, 21, 26, 44. The minimum reagents
used include gold (III) chloride hydrate and trisodium citrate dehydrate13,

26

. An example of

AuNP synthesis involves the preparation of a specific volume of gold hydrochlorate (HAuCl4)
heated with a hotplate using vigorous stirring. Separately, a sodium citrate solution would be
prepared. After rapid injection of the sodium citrate solution into gold hydrochlorate solution, the
reaction was allowed to occur and naturally cool to room temperature. The molar ratio of the
sodium citrate to gold hydrochlorate is the primary factor in the determination of AuNP size, with
secondary factors including the time provided for nucleation and growth as well as temperature11,
26, 44

. Synthesized AuNPs can be characterized with a variety of techniques including dynamic

light scattering (DLS), UV/Vis spectroscopy, and transmission electron microscopy (TEM)35, 37.
The Turkevich method is ideal for the ability to consistently control size with the ratio of the
reagents, but it is not without limitations26. The synthesis of non-spherical shapes requires
deviation from the Turkevich methods, involving different reagents and methodology. For
2

example, hexagon AuNPs have been synthesized using D-glucose as the reduction agent instead
of

citrate37.

Additionally,

several

different

shapes

have

been

synthesized

using

cetyltrimethylammonium bromide in varyingconcentrations with AuNP seeds37.

1.1.2 Gold Nanoparticle Applications
While there are an inherent variety of applications suitable for the use of gold AuNPs, the
biomedical applications pertaining to interaction with immunoglobulins maintain greater
relevance in this application. Gold nanoparticles have been used in bioimaging via several
different techniques. For example, AuNPs have been used as labels for the imaging of several
cells via TEM10, 12. This process involves the conjugation of the AuNP to antibodies specific to
an epitope on the specific cell type, taking advantage of the amplified electronic interaction in
comparison with conventional probes19,

23, 45

. This includes light field and dark field

microscopy12. In reference to diagnostic applications, there are several assays that have
successfully implemented AuNPs. Namely, sol-particle immunoassays utilize antigen-specific
immunoglobulins conjugated to AuNPs in solution13. The conjugated AuNPs then form
aggregates that can be detected via colorimetry or DLS18, 36, 39, 51. Lateral flow immunoassays
have also been utilized via immobilizing immunoglobulins to the surface of a thin gold sheet and
flowing the solution over them12,

13, 19

. Using these techniques, antigens that bind to the

immobilized antibody change the surface plasmon resonance of the gold sheet, enabling
detection19.
There are several in vivo applications utilizing AuNP for a variety of roles. However, there has
yet to be major success with in vivo applications due several complications involving delivery and
excretion28, 29. Several studies have noted the accumulation of AuNPs in the liver, for example,
which could potentially result in negative cytotoxic effects. Furthermore, there have been several
studies with mixed results on the uptake or removal by the immune system upon distribution via

3

circulation. If these difficulties can be understood and overcome, techniques such as drug
delivery and photothermal therapy will become more successful implementations of AuNPs. To
that end, research has begun to suggest potential insight, including size dependency regarding
immuneinteractions and the potential for conjugations.

1.1.3 Surface Plasmon Resonance
Surface plasmon resonance (SPR) is a property of metallic particles that is caused by the interaction
between the light and the free electrons on the metallic nanoparticle surface. Historically, this
phenomenon was observed in stained glass windows, as the red coloring in the windows would later
be attributed to gold in the form of nanoparticles, a detail that wouldn’t be discovered until later.
SPR is attributed to the oscillation of electromagnetic light fields interacting with the free electrons
in the metal, causing the free electrons to resonate with the frequency of visible light (Figure
1.3)20,

49

. For AuNPs, this oscillation occurs in the conduction band electrons, and is called

localized surface plasmon resonance (LSPR)3. The LSPR of AuNPs is affected by size, shape,
and the environment of the particle13, 50. With respect to size, larger AuNPs appear towards the
longer wavelengths of the spectrum, while smaller AuNPs appear towards the shorter wavelengths
of the spectrum (Figure 1.2). Regarding shape, AuNPs are typically spherical, but ‘urchin’ shaped
AuNPs experience a UV shift in visible color when compared to a spherical AuNP of the same
size20. The differences observed due to size and shape can be explained by the nature of the light
extinction present in the AuNPs20.
There are two major contributors to light extinction experienced in AuNPs – absorption and
scattering. Absorption occurs as conduction-band electrons oscillate in accordance with specific
wavelength within incidence light, which is dependent on the metal polarizability of the specific
nanoparticle. This is the primary contributor to light extinction in smaller nanoparticles. As
4

particle size increases, so does the role of scattering in overall light extinction. Scattering
typically involves the refraction of absorbed light, at either elastically (Rayleigh scattering) or
inelastically (Raman scattering). However, the specific scattering phenomenon and how it is
characterized can be determined by the size of the particle and the wavelength of the interaction
light. Specifically, AuNPs specifically have been characterized and studied via the Mie theory of
scattering3.

Figure 1.2: AuNP solution at varying sizes. As can be seen, the color of the AuNP changes from
red to purple as the size of the particle increases.33

Figure 1.3: Surface plasmon oscillations in spherical AuNPs as the result of an incoming light
wave.9

5

1.2 Dynamic Light Scattering

Dynamic light scattering (DLS), also known as quasi-elastic light scattering, is a technique for
the size analysis of nanoparticles. Specifically, DLS analyzes the Brownian Motion of a particle
in solution, which can be measured by observing the scattering light intensity fluctuation in the
particle solution49.
The effect of Brownian motion is inversely proportional to the particle size, meaning smaller
particles diffuse more quickly while larger particles diffuses more slowly39, 49. The process of
DLS involves the utilization of a monochromatic light source, typically a laser, that is shot
through a series of polarizers into the sample39. The intensity of the laser, controlled via
attenuation, can be adjusted to fit into a particular sample solution. A laser beam that is too
powerful may saturate the detector, while a laser with power that is too weak will not cause
enough light scattering intensity. Size, shape, and chemical properties of the particles in solution
all affect the photon interaction and resulting scattering10,

49

. DLS measures and analyzes

Brownian motion using a correlation function, which correlates the photon fluctuation to particle
size39. While DLS can also be used to analyze scattering light intensity, the main application
utilized DLS is to determine the particles size as well as size distribution of particles in a
solution39. When AuNPs interact with immunoglobulin isotypes, the interaction will lead to
individual nanoparticle size increase or nanoparticle aggregate formation. As a result, the
interaction between AuNPs and proteins may bemonitored and studied kinetically using DLS.

1.3 UV-Vis Absorption Spectroscopy and Colorimetry

Spectroscopy analyzes the way matter absorbs and emits electromagnetic radiation, using specific
wavelengths of the spectrum. Spectrometry has uses such as imaging and detecting any interactions
6

that occur within a sample.
UV-Vis spectroscopy measures the light absorbed by a sample solution. The absorbance value
correlates to the color of the respective molecule or nanoparticle material, and reflects the nature
of the energy transfer from the light to the molecules or materials14. In addition to chemical
composition, Beer-Lambert law states that absorbance is also directly proportional to the
concentration of the molecules or nanoparticles in a sample solution. In metallic nanoparticles,
including AuNPs, the nanoparticles absorb light around their surface plasmon resonance (SPR)
wavelength region and this wavelength is reflective of the size, surface chemistry, composition,
and aggregation state of the nanoparticles. Upon interaction with the proteins such as
immunoglobulin isotypes, it is expected that due to the surface change of the AuNPs or aggregate
formation, the UV-Vis absorption spectrum of the AuNPs will change3,

14, 36

. Therefore, UV-Vis

absorption spectroscopy is a valid method to study the AuNP-immunoglobulin interactions.
Colorimetry, similar to UV-Vis spectroscopy, measures the absorbance of light in sample
solutions. However, colorimetry is a more limited than UV-Vis spectroscopy. Specifically,
colorimetry measurements only occur at one wavelength of light, as opposed to the range that is
used in Uv-Vis Spectroscopy. Although providing more limited data in comparison to Uv-Vis,
colorimetry is much more cost effective, and therefore a good to for gathering preliminary data.

1.4 The Immune System

The immune system is comprised of the biological defense mechanisms that are responsible for the
detection, elimination, and resistance of harmful or unwanted entities. The immune system consists
of innate and adaptive immunity (Figure 1.4), which work in conjunction against both initial and
subsequent antigen interactions15, 17, 34. This involves a variety of cells and proteins that work

7

in cascades and pathways designed for different encounters that the body can be presented with.
A properly functioning immune system effectively differentiates between and self and non-self
entities, responds quickly to an initial infection, and effectively neutralizes and eliminates antigens
with minimal collateral damage to healthy tissues6, 17. Failure or improper function of the immune
system can result in allergies, auto immune deficiencies, or illness.

Figure 1.4: Overview of the subsets of the immune system.2

1.4.1 Immune Cells and Proteins
Dendritic cells, specialized myeloid cell that is induced by infection to take up antigens, are an
example of antigen presenting cells. Antigen presenting cells are a crucial link between adaptive
and innate immunity. Dendritic cells intake antigens process them into peptides, and present them
to T cells via major histocompatibility complexes (MHC)15. Neutrophils and macrophages are
both examples of phagocytic cells, and are among the first to respond to an antigen invasion28.
Phagocytic cells uptake antigens and degrade them with a combination of degradative enzymes
and toxic effector molecules.
Lymphocytes are hematopoietic cells that mediate adaptive immunity. There are two types of
lymphocytes, being B lymphocytes (B cells) and T lymphocytes (T cells), which each have a
8

specific role in immune response15,

34

. The role of B cells is most heavily associated with

immunoglobin (Ig) production. Naïve B cells contain surface bound Igs, with each naïve B cell
containing Igs with unique binding region. Upon binding of antigen (either soluble or membrane
bound), Igs are released from the surface of the b cell15. This also serves to activate the naïve B
cell into a plasma cell, which continues to create and release Igs with the exact binding region as
the surface bound Igs. A portion of plasma cell will continue to mature into memory cells for
future interactions withthat specific antigen.
The other lymphocytic cell is the T cell. There are two main subsets of T cells, cytotoxic (Tc) T
cells and helper (Th) T cells. Cytotoxic T cells primarily kill infected cells, while helper T cells
regulate cellular and humoral immune responses. The determination of Tc vs Th involvement is
dependent both the antigen presentation molecule and the associated cluster of differentiation (CD)
molecule15. Regarding antigen presentation, several different cells type contain major
histocompatibility complexes (MHCs). MHCs are gene complexes that codes for a diverse group
of related protein molecules expressed on all nucleated cells, as well as some immune cells, that
bind antigenic peptides for detection by T cells34. MHC 1 presents antigens that were synthesized
within the cell, while MHC 2 presents external antigens that are taken in and digested. The T cell
have either the CD4 or CD8 clusters the allow differentiation regarding MHC binding. Cytotoxic
T cells are CD8+, with CD8 further enabling effective binding to MHC 1. Furthermore, helper T
cells are CD4+, with CD4 assisting with differentiation and binding of helper T cell receptors to
MHC2 complexes41.
T helper cells can further differentiate into T helper 1 (Th1) and T helper 2 (Th2) cells, depending
on the specific cytokines present at the activation site4, 25. Th1 cells, induced by the presence of
IL-12, are characterized by transcription factor t-bet expression as well as the production of IL-2,
IFN-gamma, and lymphotoxin15, 16. Th2 cells, induced by IL-4, are characterized by transcription
factor GATA-3 expression and the production of IL-4, IL-5, IL-9, IL-13, and GM-CSF15, 16.
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While Th1 cells have been shown to support cell mediated response, and Th2 cells have been
shown to support humoral responses, there is still further understanding needed into the induction
of Th1 and Th2 responses.
Immunoglobulins, also known as antibodies, are soluble, y-shaped proteins that have two
functions5, 27. The first function is binding to an antigen, which can neutralize the binding regions
on an antigen5,

22

. The second function is the signaling of immune cells. Igs are divided into

different categories called isotypes, with each category having different characteristics and
functions34. Ig production typically involves the antigen recognition of a t-lymphocyte from an
antigen presenting cell, and is regulated to determine that the appropriate antibody is synthesized
for each scenario15.

1.4.2 Innate Immunity
Innate immunity serves as the first line of defense against invasions from external antigens. In
addition to detection and elimination of non self entities, the innate system is also responsible for
the elimination of apoptotic or senescent cells46. Comparatively, the innate immunity responds
much more quickly than the adaptive immune system, but does not contain the same level of
specificity, employ the same cells and mechanisms in response to each encounter regardless of any
previous interaction with the antigen.
Innate immunity includes physical barriers, such as epithelial cell and mucosal layers46.
Additionally, innate immunity comprises of antigen presenting cells and phagocytic cells, which
are involved in the degradation of antigens as well as the activation of the adaptive immune
system17. The Toll-like receptors (TLRs) contribute to the nature of innate specificity. TLRs
recognize PAMPs (pathogen-associated molecular patterns), yet PAMPS are not inherently
unique amongst antigens, providing a more general differentiation that adaptive immunity34.
10

1.4.3 Adaptive Immunity

Figure 1.5: Structure of various immunoglobulin isotypes. As can be seen IgM is a pentamer, IgA
is a dimer, while IgG, IgD, and IgE are all monomeric. Even amongst monomeric forms there are
differences, such as the IgE having a long heavy chain, or IgG have a different sulfide bond.1

The Adaptive Immunity, while reacting more slowly than innate immunity, provides a high-level
of specificity that is advantageous for subsequent encounters with an antigen46. As opposed to the
innate system the utilizes the same response mechanism in response to each non self entity, the
adaptive immune system uses this high level of specificity to activate a response appropriate for
the specific antigen15. The specificity of the response also minimizes collateral damage. Adaptive
immunity is heavily dependent upon the function of B cells and T cells. T Cells have a role in
antigen presentation, cell recruitment, and facilitated cell death. B cells are responsible for Ig production and immune memory34. There are five type of Igs in mammals: IgA, IgD, IgE, IgG, IgM
– each with different properties and antigen dependent function (Figure 1.5). General Ig functions
include agglutination, complement activation, opsonization, cytotoxicity, and neutralization31, 40.
In humans, specific Ig isotypes have been correlated to specific functions. Ig A has been associated
with mucosal immunity, and Ig E corresponds with parasitic defense and allergic response. IgG
along has been linked to opsonization, complement activation, and neonatal immunity31, 40. IgM
11

and IgD are both Naive B-cell receptors, with IgM having the additional functions of complement
activation and the secretion of antibodies50. Ig sizes and helper T cell association is listed in Table
1.1.
Table 1.1: Immunoglobulin information including form, molecular weight, and associated T-helper
cell pathway.
Ig Type
HUMAN
IgA
IgD
IgE
IgG
IgM
BOVINE
IgA
IgD
IgE
IgG
IgM
MURINE
IgA
IgD
IgE
IgG
IgM

Ig Form

Molecular Weight (kDa)

Dimer
Monomer
Monomer
Monomer
Pentamer

320
190
184
150-170
970

Dimer
Monomer
Monomer
Monomer
Pentamer

385-430
180
190
150-160
1030

Dimer
Monomer
Monomer
Monomer
Pentamer

350
180
190
160
900

Th1

Th2

IgG1, IgG3 IgG4

IgG2

IgG1

IgG2a

IgG1

1.5 AuNP Interactions with the Immune System

There are several documented observations of AuNP interactions with the immune system. As
previously stated, several studies initially appeared to present conflicting results, showing varying
levels of immune response. However, as studies further analyze the interaction, there appear to
be factors of AuNPs that are correlated to the level of immune response. An early documentation
of AuNP-immune interaction was with macrophages38. This study observed the
12

uptake of AuNPs by macrophages, and noted that no inflammatory cytokines (TNF-alpha and IL1beta). Based on these results, the study found AuNP nonimmunogenic. Further studies would later
provide contradictions to this, such as another study which would observe the elevated production
of IL-1, IL-6 and TNF-alpha47. A notable difference between the two studies was the size of the
AuNP, with the initial study using a much smaller (3nm) AuNP, compared to the 20-40nm
AuNPs used in the latter study.
Further studies would further analyze the nature of the inflammatory cytokine production
regarding AuNP, with the finding being that the level of interaction occurred within a size
dependent manner30, 42. An example includes a study that compared the observed response from
both 2nm and 12nm AuNPs individually, which observed a higher immune cell response in the
latter. Coatings have also been taken into consideration, as a coating such as PEGylation has the
potential to disguise the AuNP, but not without increasing overall particle size. These studies
would note some success with reducing immune activity, albeit in a size dependent manner as
well. This observation has drawn interest for the use of macrophages to disguise or protect
AuNPs for uses such as photothermal therapy8.
Dendritic cells also have interactions with AuNPs, which has presented the opportunity of AuNPs
to be used in antigen presentation. To this end, AuNPs has been successfully used to present
Epstein-Barr virus7. The uptake of the AuNP-virus conjugate resulted in presentation via MHC 1
to CD4+ T cells. The level of AuNP response of dendritic cells is dependent on both the
properties (composition and charge) and dose.
Antibody production via AuNP presence has drawn most interest in antigen presentation.
Conjugation of antigens to AuNPs allows for the activation of antigen-specific antibodies. This
can prove beneficial with antigens with low molecular weight or low immunogenicity.
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Figure 1.6: The proposed interactions of citrate capped AuNPs with human IgG and IgM48.

For Igs specifically, there has recently been observations made into the details of its interaction
with AuNPs. Regarding citrate capped AuNPs, Ig interaction either occurs electrostatically with
the citrate or directly with the gold via the displacement of the citrate, as shown Figure 1.6 48. This
variation in interaction has been shown to exist within different isotypes. For example, positively
charged human IgM has been shown to interaction with negatively charged citrate covered
AuNPs electrostatically. Also, due to the conformation of the IgM isotype, a single isotype may
have interactions with multiple AuNPs. Simultaneously. Human (and rabbit) IgG have been
shown to interact with AuNPs differently. In this instance, the IgG isotype displaces the citrate
ligand and binds directly with the metallic core of the AuNP.
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Figure 1.7: The agglutination of several different IgG1 and IgG3 variants with swapped constant
domains27.

The domains within and individual Ig also impact the characteristics of the AuNP-Ig interaction
that occurs. A study comparing antigen binding and agglutination of mouse IgG1 and mouse IgG3
serves to show the effect of varying domains between the two isotypes. In the study, both the antigen binding and agglutination were observed when swapping various components of the constant
region27. It is understood that the variable region plays a critical role in the affinity of antigen
binding, but this study demonstrates that antigen binding, as well as hemagglutination, are
influenced by the constant region as well. As can be seen in the study, swapping the CH2 domain
individually between the IgG1 and IgG3 isotypes result in the greatest change when compared to
the original isotypes (Figure 1.7). Furthermore, swaps in the constant region were also shown to
influence the affinity of antigen binding. Considering this, it is also possible that differences in
the structure (amongst the light and heavy chains of the variable and the constant region) of the
murine, bovine, and human isotypes of the same Ig type may result in different levels of change
15

regarding hydrodynamic diameter and absorbance change. For Bovine IgG1 and IgG2 specifically,
Figure 1.8 represents a potential difference in the two isotypes in their interaction withAuNP43. As
can be seen, bovine IgG1 binds the surface of the AuNP, but does lead to aggregate formation.
Bovine IgG2, in fact, binds to the surface of the AuNP to an extent that further leads to aggregate
formation.

Figure 1.8: Visualization of the differing interactions of bovine IgG1 and IgG2 with AuNPs.43

1.6 Specific Aims of Thesis Research

The purpose of this study is to analyze the interaction between AuNPs and specific isotypes of
immunoglobulins taken from several species. Specifically, this study seeks to identify any
correlation made between the nature of the interaction between specific immunoglobulin isotype
with AuNPs and the immunoglobulins potential association with T helper 1 and T helper 2 cell
pathways. Using techniques such as DLS, Colorimetry, and UV spectroscopy, it is possible to
collect kinetic data of each interaction to observe not only the formation of Ig-AuNP complexes,
but also the rate in which they occur. This would further the understanding of the nature of the
immune systems interaction with the AuNP, including how AuNPs are identified by the immune
system.
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CHAPTER 2: METHODS AND MATERIALS

The use of DLS for this study provided kinetic data regarding the hydrodynamic diameter of the
AuNP-Ig complexes, which provides information regarding the change in size cause by the
formation of the complex; additionally, colorimetry and UV-Vis provided absorbance data,
which can provide insight into the chemical nature of the interaction. Notably, UV-Vis does
provide a greater absorbance spectrum than colorimetry, which only provides the absorbance at a
single wavelength.The combination of these data sets can provide an improved understanding the
overall AuNP-Ig interaction.

2.1 Chemicals

AuNPs were received from Nano Discovery Inc. The specific composition of the product is
proprietary information of the company. All immunoglobulin isotypes, concentrations, and
commercial source are listed in Table 2.1. The immunoglobulin protein products were stored at a
temperature of 4oC. For samples involving mixed IgG1/IgG2 solutions. The appropriate amount
of IgG1 and IgG2 was added and pipette mixed in cuvette prior to the addition of AuNPs, with
specifications for the volumetric ratios and concentrations listed in Table 2.2. For the preparation
of AuNP-Ig mixed samples, Ig samples were removed from cold storage and a smaller volume
AuNP solution was collected from stock solution. After the combination of AuNP and Ig into a
cuvette via micropipette, solution was pipette mixed three times, proceeding by vortex mixing
for 5 seconds, before being used for analysis. The appropriate amounts AuNP and Ig were mixed
to achieve the ideal volumetric ratio, which varied by sample. Prepared samples included
60uL:3uL (AuNP:Ig) and 50uL:5uL for DLS samples, 100uL:10uL for UV-Vis samples, and
100uL:10ul, 50uL:5uL, and 50uL:2.5uL for colorimetry.
17

Table 2.1: Immunoglobulin Sample Information
Ig Isotypes
Company
Concentration
Cat.
BOVINE
IgG1
BioRad
1 mg/ml
pep003
IgG2
BioRad
mg/ml
pep004
IgM
Sigma
1 mg/ml
18135
HUMAN
IgG1
Abcam
3 mg/ml
ab90283
IgG2
Abcam
2.2 mg/ml
ab90284
IgG3
Abcam
2.2 mg/ml
ab118462
IgG4
Abcam
1.5 mg/ml
ab183266
IgA
Abcam
2.4 mg/ml
ab91025
IgM
Sigma
1 mg/ml
18260
MURINE
IgG1
Thermofisher
1 mg/ml
02-6100
IgG2a
Thermofisher
1 mg/ml
02-6200
IgG2b
Thermofisher
1 mg/ml
02-6300
IgG3
Novus Bio
0.5 mg/ml
Img5119A

Table 2.2: Mixed Ig Sample Ratios
Mixed
Ig Ratio
(IgG1:Ig
G2)

10:1
5:1
2:1
1:1
1:2
1:5
1:10

Volume
IgG1
(uL)

Volume
IgG2
(uL)

IgG1 Ratio
Concentration
(mg/ml)

IgG2 Ratio
Concentration
(mg/ml)

IgG1 Sample
Concentration
(mg/ml)

IgG2 Sample
Concentration
(mg/ml)

40
25
20
20
10
5
4

4
5
10
20
20
25
40

0.910
0.833
0.667
0.500
0.333
0.167
0.091

0.091
0.167
0.333
0.500
0.667
0.833
0.910

0.083
0.076
0.061
0.045
0.030
0.015
0.0083

0.0083
0.015
0.030
0.045
0.061
0.076
0.083
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2.2 Dynamic Light Scattering

Dynamic light scattering analysis of all tested sample solutions was performed using a D2Dx-R
DLS system from Nano Discovery Inc. The system is equipped with a 0.4 mW 635 nm laser. The
system allows continues and automatic size measurement in every 30 s. Samples with varying
volumetric ratio of AuNPs and Ig proteins were measured to observe any potential change in the
nature of the interaction. Measurements of the hydrodynamic diameter were collected at 0s, 30s,
60s, 90s, 120s, 150s, 180s, 210s, 240s, 270s, and 300s. The DLS data was initially collected as
the hydrodynamic diameter of the sample at the time of collection. The data was then plotted as
the difference between the initial (0s) hydrodynamic diameter and the specific diameter value
respective to the collection time. The initial (0s) value was an average of several DLS
measurements of the pure AuNP sample used in the experiments. In analysis of the data, an
increase in hydrodynamic diameter was correlated with the formation of the AuNP-Ig complex.
The initial size of the Ig isotype being observed is a considerable factor in the change of diameter,
although the exact contribution is also determined by the specific type of interaction exhibited by
the isotype.

2.3 Colorimetry

Colorimetry analysis of all tested sample solutions was performed using a LaMotte1500 UDV
Absorbance colorimeter. The wavelength of the colorimetry was set to 596 nm for all solutions.
Samples with varying volumetric ratio were measured to observe any potential change in the nature
of the interaction. Absorbance measurements were collected at 0s, 30s, 60s, 90s, 120s, 150s, 180s,
210s, 240s, 270s, and 300s. The colorimetry data was initially collected as the absorbance value of
the sample at the time of collection. The data was the plotted as the difference between the initial
(0s) absorbance value and the specific absorbance value respective to the collection time. The
initial (0s) value was zero. In analysis of the colorimetry data, a positive absorbance change was
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associated with the formation of the AuNP-Ig complex. The absorbance data provides information
regarding the behavior of the electrons in solution, which is not mutually exclusive to the overall
sized of the complex. As such, the absorbance data in conjunction with hydrodynamic can provide
more circumspect data as to the nature of the interaction.

2.4 UV/Vis Spectroscopy

UV-Vis Spectroscopy analysis of AuNP-Ig interaction products was performed using SPECTROstar
Nano microplate reader (BMG Labtech). This allows for the spectrum (220-1000nm) in less than
a second per well. The SPECTROstar Nano is equipped with a CCD spectrophotometer with the
optical density sensitivity range of 0-4. Accuracy is less than 1 percent at an optical density value
of 2, while precision at an optical density value of 2 and 1 is less than .5-.8 percent and less than
.5 percent respectively. Absorbance measurements were collected at 30s, 120s, and 300s. The
SPECTROstar provides the absorbance data for all wavelengths from 220-1000nm. Analysis of
the UV data can provide data involving the individual components in solution. Specifically, the
individual components of the solution can be potentially correlated to specific wavelength ranges.
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CHAPTER 3: RESULTS AND DISCUSSION

3.1 Dynamic Light Scattering to Measure the Change of the Hydrodynamic Diameter due to
AuNP-Immunoglobulin Interaction
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Figure 3.1: DLS data of the AuNP-Ig interactions amongst all isotypes. Each solution contained
50 uL AuNP and 5 uL of the respective immunoglobulin isotype. Initial AuNP measurement was
averaged to be 57.46 nm. Measurements were collected every 30 seconds for a total 300 seconds.

Dynamic light scattering was used to monitor the change in hydrodynamic diameter of
interactions between AuNPs and all antibody isotypes in solution. As previously stated,
measuring the hydrodynamic diameter provides information regarding any conjugation or surface
interactions experienced between the AuNP and immunoglobulins. That being stated, observing
the change in size does independently provide insight into the nature of the interaction. As a
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standard, the initial “0 second” measurement in all experiments was determined via calculation of
the average based on several DLS measurements of the pure AuNP solution used in the
experiment. As seen in Figure 3.1, Human IgM displayed both the largest overall hydrodynamic
diameter (485.6 nm). All of the samples can be generally categorized into two distinct groups,
being the isotypes that demonstrated relatively substantial increase in hydrodynamic diameter,
and the isotypes demonstrated minimal or negligible change in overall experiments. With respect
to factors that may potentially contribute to the size distribution amongst the samples, there are
several to be mentioned. While antibodies categorically contain a y-shaped protein comprised of
a binding region and a constant region, there are observable differences in structure amongst
isotypes. As can be in Figure 1.5, potential differences amongst immunoglobulin isotypes
include the difference in constant region subunits as well as the different amounts of y-shaped
proteins contained within them. Specifically, IgM is pentameric, IgA is dimeric, and IgG is
monomeric. Additionally, the differences in structure correlate to difference in size and
molecular weight (Table 1.1).
Regarding structure, there has been several studies that provide insight into the nature of some of
the specific isotype interactions. For instance, Human IgM and Human IgG both have proposed
models of interaction. With Human IgM, it is proposed that the pentameric form enables one
IgM immunoglobulin to interact with multiple AuNPs via the antigen binding region interaction
with the citrate capping, leading to eventual crosslinking via direct AuNP-Ig interaction21. The
Human IgG model presents of different method of interaction, proposing that is in fact the constant
region that interacts with the AuNP. In this interaction, the Human IgG interacts directly with
the AuNP metal core, leading to aggregation via the irreversible reaction of the immunoglobulin
variable regions21. Comparing these interactions provide insight into the role of immunoglobulin
structure as well as size. IgM is pentameric, and therefore it is unlikely for the constant region
of IgM to have any interaction with an AuNP. Expectedly, this may also be the case for IgA
which is a dimer. When observing the data in Figure 3.1, the IgM samples were shown to have
the greatest overall hydrodynamic diameter, with a 98 nm difference between Bovine IgM and
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Human IgG1. The level of influence attributed independently by the size and structure is difficult
to determine, but IgM overall has been shown to create the greatest change in hydrodynamic size.
Exploring isotypes and sample sources to further explore a correlation between isotype and change
in diameter, a large amount of variation amongst the results of the different IgG isotypes. Notably,
the reported hydrodynamic diameter at 300 seconds for Human IgG1 is 277.8 nm, while Mouse
IgG1 only reported a hydrodynamic diameter of 73.9 nm after 300s. Both Human and Mouse
IgG1 are monomeric IgG isotypes of similar sizes, yet the contrast in their size as a result of their
interaction with AuNPs is apparent. Furthermore, Human IgA is reportedly larger in size than all
of the selected IgG immunoglobulins, yet it only reported an overall 84.9 nm diameter. This data
indicates that while size and structure may be contributing factors regarding AuNP-Ig interaction,
there may be one or more outlying factors that have a greater influence on the potential interaction
of immunoglobulins with AuNPs. The IgM isotypes (both human and bovine) experienced a much
larger change.
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Figure 3.2: DLS data of the AuNP-Ig interaction of both bovine and Human IgM isotype samples.
Each solution contained 60 uL AuNP and 3 uL of the respective immunoglobulin isotype. Initial
AuNP measurement was averaged to be 82.16 nm. Measurements were collected every 30 seconds
for a total 300 seconds. Human sample experiments were completed in triplicated, while bovine
sample experiments were repeated five times, resulting in 6 total experiments.
Figure 3.2 depicts the change in hydrodynamic radius for both Bovine and Human IgM samples,
respectively. Upon analysis of the results, it can be seen that Bovine IgM exhibited a much lower
average overall hydrodynamic diameter (314.62) nm in comparison to Human IgM (791.6 nm).
It is also observable the presence of variation amongst the measurements of the bovine samples.
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This may be due several factors that overall effected the homogeneity of the sample solutions,
or may suggest the influence of unknown factors in the interaction. While there exists variation
throughout the human sample measurements, the final hydrodynamic diameter of all human sample
measurements is much more similar than what is observed in the bovine sample measurements.

3.1.2 DLS of AuNP Interaction with Bovine and Mouse IgGs
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Figure 3.3: DLS data of the AuNP-Ig interaction of both Bovine and Mouse IgG isotype samples.
Each solution contained 60 uL AuNP and 3 uL of the respective immunoglobulin isotype. Initial
AuNP measurement was averaged to be 82.16 nm. Measurements were collected every 30 seconds
for a total 300 seconds. All sample experiments were completed in duplicate.
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In Figure 3.3, the results of the Bovine and Mouse IgG samples. In the Bovine samples, both
IgG1 and IgG2 exhibited similar average overall hydrodynamic diameter (107.5 nm and 106.6 nm
respectively). However, the overall plot reveals a difference in the kinetics of each reaction. As
can be seen, Bovine IgG1 approached the overall diameter much more rapidly, reaching a diameter
of 108 nm in only 60 seconds. In the IgG2 Bovine samples, while there was a spike in the first 90
seconds (reaching 102.7 nm), afterwards the reaction gradually approached the overall diameter.
In Mouse IgG samples, IgG3 exhibited greater kinetic change as well as a greater average overall
change (137.7 nm) in comparison to IgG1 and IgG2a+b (average overall change of 104.1 nm,
106.9 nm, and 111.8 nm respectively).

3.1.3 DLS of AuNP Interaction with Human IgA and IgGs
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Figure 3.4: DLS data of the AuNP-Ig interaction of both human IgG and IgA isotype samples.
Each solution contained 60 uL AuNP and 3 uL of the respective immunoglobulin isotype. Initial
AuNP measurement was averaged to be 82.16 nm. Measurements were collected every 30 seconds
for a total 300 seconds. Sample experiments were performed in duplicate.
Figure 3.4 contains data regarding Human IgA and IgG samples. Comparatively IgG3 and IgG1
both exhibited greater average overall change than IgG2, IgG4, and IgA. IgG3 exhibited the highest
average change of 252.5 nm, although there was a notable difference observed between the two
tests performed (236.5 nm vs 268.4 nm, resulting in a 31.9 nm difference). The IgG1 samples
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exhibiting and average overall diameter of 218 nm, while exhibiting kinetics very similar to IgG3.
IgG2 had an average overall diameter of 150.3 nm, which is 67.7 nm less than IgG3, which is more
than double the difference between IgG3 and IgG1 (34.5 nm). IgG4 and IgG4 exhibited similar
kinetics and overall change (121.7 nm and 119.5 nm respectively).
3.1.4 DLS of Isolated Interactions
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Figure 3.5: DLS data of the AuNP-Ig interactions of both bovine IgG1 and IgG2 individually.
Each solution contained 50 uL AuNP and 5 uL of the respective immunoglobulin isotypes, with
or water (to serve as a control). Measurements were collected every 30 seconds for a total 300
seconds. Control (H2O) and IgG1 experiments were completed in duplicate. IgG2 experiments
were performed a total of four times.
Figure 3.5 is data regarding AuNP interactions with Bovine IgG1 and IgG2 over extended time.
In this experiment water served as a control. Both water and IgG1 exhibited similar kinetic trends
over the entirety of the 15-minute experiment, with average overall diameters of 63.15 nm and
73.45 nm respectively. Overall change in diameter is -5.75 nm and 7.15 nm respectively, which is
relatively negligible. IgG2 , however exhibited greater change (237.3 nm) , starting with an 86.925
initial diameter, and resulting in an average overall diameter of 324.3 nm. Notably, the initial AuNP
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diameter varied throughout he samples, ranging from 61.9 nm-99.3 nm. This variation may have
some attribution to the variation in results among the repeated experiments of the same samples.

3.2 Colorimetry to Measure Change in Absorbance due to the GNP-Immunoglobulin Interaction
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Figure 3.6: Colorimetry data of AuNP-Ig interaction amongst all isotypes. Each solution contained
100 uL AuNP and 10 uL of its respective immunoglobulin isotype. Measurements were collected
every 30 seconds for a total 300 seconds. IgM sample experiments were performed in duplicate.

Colorimetry was used to provide absorbance data regarding the interaction between the AuNP and
immunoglobulin. As AuNP absorbance has been linked to the oscillation of conduction band
electrons, changes in the absorbance behavior of an AuNP would be indicative of a change in
behavior of the conduction band electrons, providing potential insight into the nature of the
AuNP-Ig interaction. Colorimetry in Figure 3.6 was used to measure the effect of the AuNP-Ig
interaction on SPR. Human IgG3 experience the greatest overall absorbance (.277), although
Human IgG1 showed the greatest increase in absorbance during the first 60 seconds of the
experiment (.118). Bovine IgG2 (.253), Human IgG1 (.225), and Mouse IgG2a (.208) all
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exhibited less of an increase in overall absorbance at a rate similar to Human IgG3. Human IgM
(.1095) and Bovine IgM(.099) both revealed a reduced amount of overall absorbance change and
increase in absorbance over time. Human IgG4 (.049), Mouse IgG2b (.046), Mouse IgG3 (.039),
Human IgG2 (.028) only showed and observable increase during the first minute, after which
negligible increase in absorbance oc curred. Human IgA interaction resulted in negligible change
in absorbance (-.001), while Bovine IgG1 demonstrated an increase during the first 30 seconds
and a decrease thereafter (-.014). Colorimetry provides more information regarding the AuNP
association among one another in the AuNP complex by measuring the change in absorbance,
with correlates to the SPR (more specifically the electron interaction) of particles in solution.
Bovine IgG1, Bovine IgG2, Human IgG1, Mouse IgG2a exhibited the highest amount of
absorbance change.
This data suggest that specific isotypes may contain AuNP interactions with a greater effect on
SPR with no strict correlation to the change in diameter, which may provide insight into the nature
of their interaction. The absorbance change in Human IgM and Bovine IgM was not as significant
as the change observed in hydrodynamic diameter, but nevertheless suggests interaction amongst
the free electrons of associated AuNPs. Human IgA experience marginal change in absorbance,
and Bovine IgG1 experienced and overall decrease in absorbance, which indicates the specific Ig
interactions occurred with minimal effect to the SPR of the AuNP. As previously suggested, comparison of colorimetry data to the DLS data, greater variation can be seen amongst the different
isotypes. To clarify, the DLS and colorimetry experiments were used to measure to different
aspects of the AuNP-Ig interactions. While dynamic light scattering measures the overall change
insize cause by the interaction, the colorimetry data measures the electron interaction of the complex. This change in electron interaction affects the AuNPs absorbance properties, which cause
the change in the absorbance value. Using the experimental data from these two techniques in
conjunction provides insight into the exact nature of the interaction.
There are several potential ways for AuNPs interact with immunoglobulins, including covalent,
ionic, and hydrophobic interactions21. Furthermore, these interactions have the potential to be
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both direct and indirect regarding AuNPs. For example, citrate is a negatively charged capping
agent often used to stabilize AuNPs that has been shown a source of indirect Ig interaction (often the case in ionic interactions). In other instances, the Ig is able to interact directly with the
metallic core of the AuNP. Comparatively, the Ig isotype samples with the largest overall hydrodynamic diameter were not directly consistent with the Ig isotypes samples that experienced the
great absorbance change. The Ig isotype sample Human IgM experienced the greatest overall
hydrodynamic diameter, but experienced comparatively lower overall absorbance change, being
only 0.005 above average, and only 40nm Bovine IgM. This seems to corroborate the
contribution of multiple factors to both formation and overall nature of AuNP-Ig complexes.
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3.2.1 Colorimetry of AuNP Interaction with Bovine and Human IgM
The bovine and human IgM samples in Figure 3.7 produced similar results overall within the repeated experiments of the respective isotypes. In the bovine sample, the experiments resulted
in a 0.105 and a 0.093 change in absorbance in the two experiments, averaging 0.099. Furthermore, the kinetic data reveals consistency in the rate of absorbance change after 30 seconds. In
the human samples, the experiment results in relation to overall absorbance change were 0.119
and 0.10 throughout the course of the experiments, averaging 0.1095 between the two. As was
seen the human duplicates, the rate of change past the 30 second mark is relatively consistent.
When comparing bovine and human samples, both samples experience a similar average overall
change, with a difference of 0.0105 between the sample overall averages. However, the kinetic
data reveals a difference regarding the rate of absorbance change, particularly before 30 seconds.
When analyzing the kinetics from 0 to 30 seconds, the human samples experience a larger change
(averaging 0.0535) than the bovine samples (averaging 0.023).
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Figure 3.7: Colorimetry data of AuNP-Ig interaction amongst all isotypes. Each solution contained
100 uL AuNP and 10 uL of its respective immunoglobulin isotype. Measurements were collected
every 30 seconds for a total 300 seconds. IgM sample experiments were performed in duplicate.

32

3.2.2 Colorimetry of AuNP Interaction with Bovine and Mouse IgGs
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Figure 3.8: Colorimetry data of AuNP-Ig interaction both bovine and mouse IgG isotype samples.
Each solution contained 100 uL AuNP and 10 uL of its respective immunoglobulin isotype. Measurements were collected every 30 seconds for a total 300 seconds. IgM sample experiments were
performed in duplicate.

In Figure 3.8, there is a comparison between bovine and mouse IgG samples. For both the bovine
and mice there was stark contrast in overall absorbance change amongst the results. In the bovine
samples, IgG1 experience a negative change, resulting in an overall absorbance of -0.014, showing
negligible change after 60 seconds. Comparatively, IgG2 had an absorbance change of 0.253, and
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exhibited a gradual increase in absorbance. In the mouse samples. The mouse samples experienced
a similar result, albeit to a different extent. Mouse IgG2a showed the greatest change (0.208), while
IgG1, IgG2b, and IgG3, resulted in similar change (0.041, 0.046, and 0.039 respectively).

3.2.3 Colorimetry of AuNP Interaction with Human IgA and IgGs
The Human samples depicted in Figure 3.9 show that the nature of the change observed in the isotypes is different. IgG3 had the greatest overall change of 0.277, followed by IgG1 with a change
of 0.225. However, IgG1 experienced the greatest change within the first 30 seconds (0.118) when
compared to IgG3 (0.078). The remaining samples – IgA, IgG2, and IgG4 – experienced less
change of -0.001, 0.028, 0.049 respectively.
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Figure 3.9: Colorimetry data of AuNP-Ig interaction both human IgG and IgA isotype samples.
Each solution contained 100 uL AuNP and 10 uL of its respective immunoglobulin isotype. Measurements were collected every 30 seconds for a total 300 seconds.

3.2.4 Colorimetry of AuNP interaction with Mixed Bovine IgG samples
Bovine IgG1 and IgG2 were mixed at varying ratios for the purpose of observing any potential
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competition or inhibition. As shown in Figure 3.10, greatest absorbance change was seen in
samples in which the IgG2 concentration was higher than IgG1. However, the difference
between the overall absorbance change and the rate of increase of the 1/10 (0.247) and 1/5
(0.201) sample was higher than what could be observed from the observed from the other
samples. The 1/2, 1/1, and 2/1 samples experienced relatively little absorbance change (0.016,
0.020, and 0.011 respectively), while the 5/1 and 10/1 sample notably displayed a decrease in
absorbance (-0.016 and -0.025 respectively). Bovine IgG2 experienced among the highest levels
of absorbance change of the isotypes test, while IgG1 resulted in the overall least absorbance
change of all selected iso- types. The Samples with the highest ratio of IgG2 (1/10 and 1/5) both
experienced considerably more absorbance change in comparison to the other samples.
Interestingly, the 1/2 behaved very similarly to the 1/1 and 2/1 samples than if the change was
directly proportional to IgG2 concentration. From this data, it can be deduced that IgG2 has a
greater influence on the SPR than IgG1. However, the results of the 1/2, 1/1, 2/1, may suggest an
interaction between the IgG1 and IgG2, as the slope of the kinetics changes substantially. One
possibility is that there may be some competitive inhibition between the IgG1 and IgG2 in the
sample, as the potential exists for IgG1 and IgG2 to interact with one another in solution.
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Figure 3.10: Colorimetry data of AuNP-Ig interaction of varying IgG1 and IgG2 ratios. Each solution contained 100 uL AuNP and 10 uL bovine IgG at its respective ratio. Volumetric breakdown
of selected ratios (IgG1:IgG2): 10:1 – 40 uL:4 uL, 5:1 – 25 uL:5 uL, 2:1 – 20 uL:10 uL, 1:1 – 20
uL:20 uL, 1:2 – 10 uL:20 uL, 1:5 – 5 uL:25 uL, 1:10 – 4 uL:40 uL.
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Figure 3.11 is a retest of bovine IgG1 and IgG2 ratio solutions with the addition of pure IgG1
and pure IgG2. The trends are comparable to Figure 3. However, pure IgG1 showed a greater
absorbance change than the 10/1 sample. Overall, there is an observable difference amongst the
different isotypes in both the DLS and colorimetry data. There is a potential correlation between
Th2 isotypes and increased AuNP interaction. The colorimetry and DLS data reveal a general correlation with this hypothesis, as the isotypes associated with Th2 experienced greater absorbance
change than the Th1 associated isotypes. Despite this, the data indicates the potential contribution
of several other factors (such as form, molecular weight etc.), as the data has not demonstrated a
predictable change correlating to the variables in the experiments.
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Figure 3.11: Colorimetry data of AuNP-Ig interaction amongst all isotype ratios. Each solution
contained 100 uL AuNP and 10 uL bovine IgG at its respective ratio. Volumetric breakdown of
selected ratios (IgG1:IgG2): 10:1 – 40 uL:4 uL, 5:1 – 25 uL:5 uL, 2:1 – 20 uL:10 uL, 1:1 – 20
uL:20 uL, 1:2 – 10 uL:20 uL, 1:5 – 5 uL:25 uL, 1:10 – 4 uL:40 uL. Standard deviation bars reflect
the triplicate tests performed for each ratio.
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3.3 UV-Vis Spectroscopy to Measure the Change in Absorbance Profile amongst Various
Ig-AuNP interactions over time

UV-Vis spectroscopy measures absorbance data over a large spectrum of wavelengths
simultaneously. This differs from colorimetry that only collects absorbance data at a particular
wavelengthat a time. By measuring he absorbance data at multiple wavelengths, there is a greater
capability to observe phenomenon such as shifts or broadening of absorbance peaks, as well as
the presence and changes of additional peaks. Figure 3.12 shows the results of UV-Vis
spectroscopy performed at a half minute, two minutes, and five minutes of samples solutions of
IgM, IgG1, and IgG2 in- dividually with AuNPs. In the IgM sample, a slight shift in the
absorbance peak and decrease in the absorbance value at the peak can be seen over the course
five minutes. Over the first half minute, the absorbance peak shifted from the control (0.966 at
577nm) to 0.953 at 583 nm. At two-minutes, a further shift can be observed with a broad
absorbance peak of 0.829 at 584-588nm.At five-minutes mark, the absorbance peak 0.815 at 585586nm. Overall, the greatest change in absorbance value was the difference between the half
minute and two-minute reading with an ab sorbance difference of .124, with the greatest shift in
wavelength was between the control and the half minute with a difference of 5nm. Additionally,
there were observable peaks in the half- minute, two-minute, and five-minute that were not
present in the control measurement. Notably, there was an additional peak at 280nm present all
non-control samples. In the half-minute sample, the peak had an absorbance value of .665, while
the two-minute and five-minute samples both had absorbance readings of 0.587 and 0.588
respectively. Furthermore, the half-minute sample had an additional peak of 0.394 at 976 nm that
was present in no other sample.
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Figure 3.12: UV-Vis data of individual AuNP-Ig interactions over the course of five minutes.
Samples include IgM, IgG1, and IgG2. A pure solution of AuNPs were used as a control, with an
absorbance peak of 0.968 at 577nm.

In the IgG1 sample there is less variation amongst the time measurements than what was present
in the IgM sample. At a half-minute measurement, there was a peak of 0.854 at 576-578nm. As
the sample progressed to the two-minute measurement, the peak shifted slightly to 0.88 at 571572nm. At five minutes, the sample again experienced a slight shift to 0.886 at 577-579nm. The
greatest change in absorbance value was the difference between the control and the half minute
measurement (0.112), while the greatest shift in wavelength was 0.006 between the two-minute
and the five-minute measurements. Once again, there were peaks that were not observable in the
control that were observable in the other samples. At a half-minute, there was an additional peak
of 0.531 at 279 nm, while the two-minute and five-minute measurements had secondary peaks
of 0.55 at 276nm and 0.556 at 279-281nm respectively. Moreover, the half-minute measurement
has yet another peak 0.232 at 974nm that is not present in any other sample. Interestingly, the
lowest absorbance value was associated with the half-minute measurement, as opposed to the twominute and five-minute measurement. This is dissimilar to what is seen in the other samples, and
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it is abnormal with respect to what could be anticipated.
The IgG2 sample exhibited the greatest change overall throughout the experiment. At the half
minute measurement, the absorbance shift resulted in a peak of 0.833 at 582nm. At the twominute measurement, the absorbance peak shift resulted in 0.809 at 582-585nm. At the five-minute
measurement, the absorbance peak as a result of a shift was 0.715 at 584-585nm. The greatest
change in absorbance value was 0.133 between the control and the half-minute measurement.
And the greatest shift in wavelength was from 0.005 between the control and the two-minute
measurement. Consistent with the other samples, there are additional peaks that are not present
in the control sample. The half-minute measurement had a peak of 0.526 to 278-280nm, while
the two-minute and five-minute measurements have similar peaks of 0.531 at 280nm and 0.501 at
280nm respectively. Furthermore, the half-minute measurement had another absorbance reading of
0.249 at 975nm. The figure is a comparison of the largest peaks of all sample measurements. The
of the samples/time in the order of decreasing absorbance value is as follows: the control (pure
AuNP sample), IgM half-minute, IgG1 two-minute, IgG1 five-minute, IgG1 half-minute, IgG2
half-minute, IgM two- minute, IgM five-minute, IgG2 two-minute, IgG2 five-minutes. As can be
seen in this distribution, the IgG1 samples experienced the overall least change in absorbance value
as well as the smallest shift in wavelength.
The IgM half minute sample was the individual measurement with the least absorbance change
with respect to the control, but the two-minute and five-minute measurements both have a greater
absorbance change the all IgG1 measurements. The IgG2 half-minute measurement had less
change than both of the later IgM samples, but the IgG2 two-minute and five-minute
measurements experienced the second greatest and the greatest change respectively. These
findings are consistent with the colorimetry data present previously; however, there are additional
peaks in the UV-Vis spectroscopy reading. In all samples but the pure AuNPs, there was a peak
near the UV end of the spectrum (within a range of 270-300nm). It is possible that these peaks
may be the result of free antibodies, or other antibodies not in complex with AuNPs. There is no
proposed ex- planation of the peaks near the IR end of the spectrum for half minute samples.
40

Table 3.1 contains information regarding the largest peak in each sample.
Table 3.1: Absorbance Peaks for GNP-Ig Samples
Measurement Sample Absorbacnce Peak Wavelength (nm)
GNP
0.968
577
IgM half minute
0.953
583
IgM two minutes
0.829
585-88
IgM five minutes
0.815
585-86
IgG1 half minute
0.854
576-78
IgG1 two minutes
0.88
571-72,583
IgG1 five minutes
0.88
570,585
IgG2 half minutes
0.833
582
IgG2 two minutes
0.809
582
IgG2 five minutes
0.715
581-84

3.4 Comparing DLS, Colorimetry, and UV-Vis Spectroscopy Data

All experimentation, including dynamic light scattering, colorimetry, and UV-Vis spectroscopy,
was performed to measure different aspects of the interaction between AuNPs and the varying
immunoglobulin isotypes individually as well as to observe any potential correlation between
interac tion behavior and th1/th2 pathway association. DLS measured the change in hydrodynamic
diameter, while colorimetry and UV-VIS measure the absorbance change. To reiterate,
immunoglobulins associated with the T-helper 1 lymphocyte associated pathways includes human
IgG1 and IgG3, bovine IgG2, and murine IgG2a; furthermore, immunoglobulins associated with
the T-helper 2 lymphocyte associated pathways includes human IgG4, bovine IgG1, murine
IgG1.
Upon further analysis, there appears to be a correlation amongst several of the isotypes regarding
their change in size and absorbance. Generally speaking, the changes observed in comparison
of the Th1 and Th2 associated. Categorically, Samples associated with Th1 pathways resulted in
greater changes in both hydrodynamic diameter and absorbance. For instance, the Th1 associated
isotype with the lowest overall hydrodynamic diameter in figure 3.1, and the lowest absorbance in
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figure 3.6, was mouse IgG2a (142.1nm and 0.208 respectively), In the same figures, Th2 associated
isotype with the highest hydrodynamic diameter and absorbance human IgG4 was (79.8nm and
0.049 respectively). This difference is reflective of the trend for Th1 to result in a larger amount of
change, associated with a greater complex formation.
Within the categories, however, less consistency is present. In particular, the way individual
samples compared to one another relatively was different comparing size and absorbance data.
Amongst Th1 associated isotypes, the greatest change in diameter (Figure 3.1) was in the human
IgM sample (485.6nm). However, the isotype with the largest absorbance change (Figure 3.6)
amongst the same group is in fact human IgG3 (0.277) and not human IgM (0.010). The same
trend was observed in Th2 as well. Even though human IgG4 had the greatest change in hydrodynamic diameter and absorbance change, bovine IgG1 and murine IgG1 shifted between the data
sets.
Several individual isotypes measurements had consistency issues regarding repeatability of
measurements. Case in point, the behavior of bovine IgG1 in Figure 3.3 is considerably different
than the behavior observed in Figure 3.1. Furthermore, the colorimetry of several samples
exhibited high levels of standard deviation amongst repeated measurements. This level of
variation was even present among the mixed bovine IgG samples. This level of variation may be
indicative of the contribution of additional external factors of the interaction (including sample
concentration and preparation).
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CHAPTER 4: OUTLOOK

In this study, interactions between gold nanoparticles and 13 different antibody isotypes isolated
from bovine, human, and murine samples are recorded via dynamic light scattering, colorimetry,
and UV-Vis spectroscopy. As stated previously, results clearly demonstrate a difference in AuNP
interaction amongst the varying isotypes. To be specific, there are certain isotypes that seemed
to have little to no interaction with AuNPs, including bovine and murine IgG1, as well as human
IgA and IgG4. Samples such as bovine and human IgM, as well as human IgG1 and IgG3,
exhibited much greater hydrodynamic diameter and absorbance changes than the previously
mentioned samples. Furthermore, it appears that there may be a correlation between the
immunoglobulin iso- types and the Ig association to Th1 associated pathways. Human IgG1 and
IgG3, as well as bovine IgG2 and murine IgG2a, are all Th1 associated immunoglobulins that
exhibited relatively higher hydrodynamic diameter and absorbance changes compared to the
other samples. Notably, human and bovine IgM also exhibited comparatively high levels of
change with respect to hydrodynamic radius and absorbance, yet have not been associated with
Th1 associated pathways. Furthermore, there were repeatability issues in the mixed sample
solutions. Several concentrations of bovine IgG1:IgG2 sample exhibited large levels of deviation,
indicating that there may be other contributing factors to the level of interaction experienced
between AuNPs and Igs. Moving forward, it would be beneficial to further the understanding of
the relationship between particle size and the interaction with the varying isotypes, as this was
not strictly tested in this study, and his been noted to influence immune response. Additionally,
there is benefit in measuring immune response in samples devoid of antibodies with specific
associations (th1 and th2, for instance) to potentially further understand and possibly isolate
immune pathways associated with in vivo presence of AuNPs.
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